Sigma Healthcare walked away from preliminary talks to buy British pharmacy chain Boots, saying the potential deal would not meet its strategic and capital investment objectives. The decision removes a possible cross-border M&A transaction and suggests management is being selective about deployment of capital. The news is modestly negative for deal expectations but limited in broader market impact.
Sigma Healthcare walked away from preliminary talks to buy British pharmacy chain Boots, saying the potential deal would not meet its strategic and capital investment objectives. The decision removes a possible cross-border M&A transaction and suggests management is being selective about deployment of capital. The news is modestly negative for deal expectations but limited in broader market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
